We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

235 hedge funds and large institutions have $3.35B invested in Arena Pharmaceuticals Inc in 2021 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 96 increasing their positions, 63 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $57.6M | Put options by funds: $32M

52% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 63

0% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 31

1% less funds holding

Funds holding: 237235 (-2)

13% less capital invested

Capital invested by funds: $3.87B → $3.35B (-$518M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
235
Holders Change
-2
Holders Change %
-0.84%
% of All Funds
4.11%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
31
Increased
96
Reduced
63
Closed
31
Calls
$57.6M
Puts
$32M
Net Calls
+$25.7M
Net Calls Change
+$9.91M

ARNA Hedge Fund Activity: Q3 2021 in Review

235 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2021, worth a combined $3.35B — down 13% from $3.87B a quarter earlier.

Fund positioning in ARNA was balanced in Q3 2021: 31 funds opened new positions, 31 closed out, 96 added to existing stakes and 63 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $68.6M. The largest seller was Holocene Advisors, exiting entirely with an estimated $83.5M sold.

  • 235 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2021, down from 237 in Q2 2021.
  • Funds reported $3.35B of Arena Pharmaceuticals Inc stock for Q3 2021, down 13% quarter-over-quarter.
  • 31 funds opened new Arena Pharmaceuticals Inc positions in Q3 2021 and 31 closed out, a net change of 0 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2021 was Janus Henderson Group, an estimated $68.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2021 was Holocene Advisors, an estimated $83.5M sold.

Based on aggregated 13F filings for Q3 2021.